RA Capital Management, L.P. 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-15 5:02 pm Sale |
2023-05-15 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 0 0.000% |
-3,984,681 (Position Closed) |
Filing |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 3,984,681 6.200% |
-1,629,747 (-29.03%) |
Filing |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 5,614,428 9.200% |
1,056,561 (+23.18%) |
Filing |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 4,557,867 8.900% |
4,557,867 (New Position) |
Filing |